2021 Good Quality aspergillus IgM testing - COVID-19 IgM Lateral Flow Assay – Genobio


Product Detail

Product Tags

Related Video

Feedback (2)

We are going to make every single effort for being excellent and excellent, and accelerate our ways for standing while in the rank of international top-grade and high-tech enterprises for COVID-19 IgM antibody, fungus glucan test reader, Mucorales Molecular Detection Kit (Real-time PCR), Welcome worldwide customers to contact us for business and long-term cooperation. We will be your reliable partner and supplier of auto parts and accessories in China.
2021 Good Quality aspergillus IgM testing - COVID-19 IgM Lateral Flow Assay – Genobio Detail:

Product Introduction

Virusee® COVID-19 IgM Lateral Flow Assay is a lateral flow immunoassay used for the qualitative detection of Novel Coronavirus IgM antibody in human whole blood / serum / plasma samples in vitro. It is mainly used in the auxiliary clinical diagnosis of novel coronavirus pneumonia.

The novel coronavirus is a positive single-stranded RNA virus. Unlike any known coronavirus, the vulnerable population for Novel Coronavirus is generally susceptible, and it is more threatening to the elderly or people with fundamental diseases. IgM antibodies positive is an important indicator of novel coronavirus infections. Detection of novel coronavirus-specific antibodies will aid clinical diagnosis.

Characteristics

Name

COVID-19 IgM Lateral Flow Assay

Method

Lateral Flow Assay

Sample type

Blood, plasma, serum

Specification

40 tests/kit

Detection time

10 min

Detection objects

COVID-19

Stability

The kit is stable for 1 year at 2-30°C

COVID-19 IgM

Advantage

  • Rapid
    Obtain result within 10 min
  • Simple
    Visually reading result, easy to interpret
    Simple procedure, without complicated operation
  • Cost-saving
    Product can be transported and stored at room temperature, reducing costs
  • Low risk
    Testing blood sample, reducing the risk of sampling process
  • Suitable for screening on-site, bedside, outpatient

Background and principle

SARS-CoV-2 emerged as a novel virus with no available treatment option and caused a serious disaster across the world. The disease caused by this virus, “COVID-19″, announced a global pandemic on March 11, 2020. Without any proper treatment and vaccine for COVID-19, people around the world are currently experiencing a worldwide emergency affecting all societies, and it has sent billions of people into lockdown. Around the world, desperate efforts are underway to curtail this pandemic while it has resulted in the collapsing of health systems and has triggered lasting geopolitical and economic changes.

Poor diagnosis of COVID-19 has also contributed to disease severity due to stress (in case of false positive) and disease spread (in case of a false negative). A lack of RT-PCR test sampling of lower tract respiratory specimens was the main reason for the misclassification of symptomatic patients as either having COVID-19 or not. A prompt diagnosis with serological testing shows SARS-CoV-2 IgG/IgM patterns in a better and understandable way of seroconversion.

The IgG/IgM assays to detect the length and origin of humoral responses against SARS-CoV-2 is very important, and these antibodies can be detected from a few days after the onset of diseases and may remain in the body even after years of infection. In the case of COVID-19, IgM and IgG response can be observed from the second week of the disease.

Serologic assays provide quick diagnostic by avoiding PCR false positive/false negative result as well as these provide antibody pattern for estimation of strength and duration of humoral immunity.

IgM and IgG antibody detection can identify suspected cases with negative nucleic acid tests. Compared with nucleic acid detection, IgM and IgG detection may provide a quick, simple, and accurate detection method for suspected COVID-19 cases.

COVID-19 IgM Lateral Flow Assay 1
COVID-19 IgM Lateral Flow Assay 2

Test process

COVID-19 IgM Lateral Flow Assay 3

Order Information

Model

Description

Product code

VMLFA-01

40 test/kit, strip format

CoVMLFA-01


Product detail pictures:

2021 Good Quality aspergillus IgM testing - COVID-19 IgM Lateral Flow Assay – Genobio detail pictures

2021 Good Quality aspergillus IgM testing - COVID-19 IgM Lateral Flow Assay – Genobio detail pictures

2021 Good Quality aspergillus IgM testing - COVID-19 IgM Lateral Flow Assay – Genobio detail pictures


Related Product Guide:

Fast and very good quotations, informed advisers to help you choose the correct merchandise that suits all your preferences, a short creation time, responsible excellent command and different companies for paying and shipping affairs for 2021 Good Quality aspergillus IgM testing - COVID-19 IgM Lateral Flow Assay – Genobio , The product will supply to all over the world, such as: Doha, Suriname, Israel, With excellent solutions, high quality service and sincere attitude of service, we ensure customer satisfaction and help customers create value for mutual benefit and create a win-win situation. Welcome customers all over the world to contact us or visit our company. We'll satisfy you with our qualified service!
  • The company has rich resources, advanced machinery, experienced workers and excellent services, hope you keep improving and perfecting your products and service, wish you better!
    5 Stars By Judy from Cambodia - 2018.10.01 14:14
    The company's products very well, we have purchased and cooperated many times, fair price and assured quality, in short, this is a trustworthy company!
    5 Stars By Eudora from Albania - 2017.08.18 11:04
    Write your message here and send it to us